News & Events
Recent News
Upcoming Events
-
PIM-Targeted PROTACs
Webinar attendees will learn about a new family of Proteolysis Targeting Chimeras (PROTACS) that selectively target Proviral Integration for the Moloney murine leukemia virus (PIM) kinases. PIM kinases play a role in cancer development and mediating resistance to radio and chemotherapy, and are overexpressed in multiple cancers. Several small molecule PIM kinase inhibitors have had minimal effect in suppressing cancer phenotypes due to the PIM kinase inhibitors promoting intrinsic resistance. By contrast, these PIM-targeted PROTACs suppress PIM kinase activity and avoid intrinsic resistance.
April 24, 2024 | 11:00 AM – 12:00 PM -
Tech Webinar: Pigment Epithelium-Derived Factor Peptides for Treating Retinal Degeneration
This webinar was originally scheduled for January 31, and rescheduled for May 22; it will now be rescheduled for fall 2024.
Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell degeneration and ultimately vision loss. A new therapeutic technology from the National Eye Institute has the potential to be a treatment option for RP patients and may also protect retinal cells from damage associated with glaucoma and age-related macular degeneration (AMD). Attend the webinar to assess the technology for partnership and licensing opportunities.May 22, 2024 | 11:00 AM – 12:00 PM -
2024 Technology Showcase
An annual event for potential industry partners and stakeholders highlighting cancer technologies and how to work with the NCI and the Frederick National Laboratory.
September 4, 2024 | 9:00 AM – 4:30 PMFrederick, MD